full year outlook ew
rate ew construct advantag
categori exposur innov pipelin pf synergi
potenti howev view stock fairli valu
result instil confid top-line recoveri trade vs
 follow better expect result beat organ
sale vs consensu ep vs consensu
surpris magnitud today share price move underscor
elev concern head quarter surround compani abil
deliv top-line turnaround today result help allevi fear
deliv solid organ growth across segment reflect
benefit strong innov healthi choic bird mari callend
contribut share gain frozen moder competit headwind
boyardee/hunt healthi growth snack yoy retail notabl
indic sale growth consist retail consumpt
impact shipment time retail
increas visibl fy outlook despit beat maintain
outlook organ sale growth modestli reduc ep
guidanc vs prior due recent divestitur
guidanc still impli organ sale improv vs flat yoy
believ abl deliv target given traction
see recent innov retail sale innov
vs continu ramp upcom launch
veget base carb replac lap easier compar pf
move organ base moreov reinvest increment
mm pf synergi behind drive top-line growth expect
rais pt vs prior remain ew ep
reflect beat outlook stronger top-line growth org sale
vs prior expect increas brand
build invest rise inflat drive gm bp yoy
expect synergi driven sg save contribut ebit margin
bp yoy rais base case pt vs prior base
ev/ebitda center-stor peer given higher
leverag pt current share price maintain ew
food unit state america
unless otherwis note metric base modelwar
base consensu methodolog
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
rate would surpris stock gave back today gain
come day
pt base ev/ebitda center-stor
peer take account higher ep growth outlook
leverag plu valu tax asset
bull case ev/ebitda plu valu tax asset
bull case ev/ebitda plu valu tax asset
sale recoveri synergi ahead plan ad strateg option pf
sale recoveri progress faster expect result deliv
acceler organ sale year synergi upsid drive bp
cumul ebit margin improv valuat re-rat
reflect potenti margin earn upsid
base ev/ebitda plu valu tax asset
base ev/ebitda plu valu tax asset
deliveri outlook drive re-rat legaci deliv strong organ
sale turn around sale trend pf ebit
margin expans bp assum synergi captur
ep benefit on-going debt paydown forecast project
ep
bear ev/ebitda plu valu tax asset
bear ev/ebitda plu valu tax asset
legaci busi pressur pf remain challeng top-line
weak across legaci busi organ sale
result greater reinvest margin expans pf
integr slow synergi realiz reinvest essenti
save back busi
advantag top-line growth outlook
legaci abl sustain
lsd organ sale growth due exposur
frozen opportun turnaround
refriger busi growth snack
reduc fundament visibl
manag strong turnaround track
record see greater risk pf
see solid hsd ep growth limit
potenti upsid mid-term
target opportun close
gross margin gap vs peer compani
set optimist target risk
downsid top-line synergi estim
valuat ev/ebitda reflect
compani rel higher leverag
top-line recoveri pinnacl food
greater expect synergi realiz
strong momentum legaci busi
potenti divestitur acceler debt
risk achiev price
continu organ sale weak pf
signific reinvest cost synergi
exhibit us retail organ sale increas
scanner
exhibit organ sale driven volum increas
exhibit gm decreas
exhibit ebit margin decreas
exhibit percentag sale
exhibit trade low end among food compani
good sold
sg sale
incom continu oper
net incom attribut conagra
cash equival
prepaid expens ca
current asset held sale
properti plant equip net
trademark intang
non-current asset held sale
current instal long-term debt
current liabil held sale
non-current liabilti held sale
accumul comprehens incom loss
total liabil stockhold equiti
flow oper activit
incom continu oper
adjust reconcil incom
depreci amort
chang oper asset liabil
prepaid expens current asset
oper continu
oper discontinu
oper activ
flow invest activ
addit pp
sale busi em invest
sale properti plant equip
purchas busi
proce collect
invest continu
invest discontinu
invest activ
flow financ activ
issuanc long-term debt
repay long-term debt net
issuanc common share
repurchas common share
exercis employe option
financ continu
financ discontinu
financ activ
effect fx cash cash equival
discontinu oper cash activ includ
add held sale beg year
less held sale year end
net decreas /increas cash
equival beg year
equival end year
